German drug companies are criticised for not focusing on useful therapeutic areas

15 September 2015 - A 2011 German law designed to lower prices of new innovative drugs has not been as successful ...

Read more →

Afatinib: added benefit in certain mutations confirmed by IQWiG

17 August 2015 - Afatinib dimaleate (trade name: Giotrif) has been approved since September 2013 for the treatment of adult patients ...

Read more →

Safinamide in Parkinson disease: no hint of added benefit says IQWiG

17 August 2015 - Safinamide (trade name: Xadago) has been available since February 2015 as add-on therapy for the treatment of ...

Read more →